Clinical and Genetic Atrial Fibrillation Risk and Discrimination of Cardioembolic From Noncardioembolic Stroke.
Lu-Chen WangShaan KhurshidSophia GunnLudovic TrinquartKathryn L LunettaHuichun Xunull nullEmelia J BenjaminPatrick T EllinorChristopher D AndersonSteven A LubitzPublished in: Stroke (2023)
Addition of polygenic risk of AF to clinical risk factors modestly improves the discrimination of cardioembolic from noncardioembolic strokes, as well as reclassification of stroke subtype. Polygenic risk of AF may be a useful biomarker for identifying strokes caused by AF.